Alloantibodies in heart transplantation

Human Immunology

Volumn 70, Issue 10, 2009, Pages 825-829

  Ho, Eric K ^a   Vlad, George ^a   Colovai, Adriana I ^a   Vasilescu, E Rodica ^a   Schwartz, Joseph ^a   Sondermeijer, Hugo ^a   Burke, Elizabeth ^a   Marboe, Charles C ^a   Itescu, Silviu ^a   Suciu Foca, Nicole ^a   Mancini, Donna ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Allosensitization; Anti HLA antibodies; Graft survival; Heart transplantation

Indexed keywords

ALLOANTIBODY; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CARDIAC GRAFT REJECTION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HEART GRAFT; HEART TRANSPLANTATION; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

AGED; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MONITORING, IMMUNOLOGIC;

EID: 70349308246     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.06.015     Document Type: Article

References (39)

1. Fenoglio J., Ho E., Reed E., Rose E., Smith C., Reemstma K., et al. Anti-HLA antibodies and heart allograft survival. Transplant Proc 21 (1989) 807-809
2. Suciu-Foca N., Reed E., Marboe C., Harris P., Yu P.X., Sun Y.K., et al. The role of anti-HLA antibodies in heart transplantation. Transplantation 51 (1991) 716-724
3. Reed E., Ho E., Cohen D.J., Ramey W., Marboe C., D'Agati V., et al. Anti-idiotypic antibodies specific for HLA in heart and kidney allograft recipients. Immunol Res 12 (1993) 1-11
4. Suciu-Foca N., Liu Z., Harris P.E., Reed E.F., Cohen D.J., Benstein J.A., et al. Indirect recognition of native HLA alloantigens and B-cell help. Transplant Proc 27 (1995) 455-456
5. Liu Z., Colovai A.I., Tugulea S., Reed E.F., Fisher P.E., Mancini D., et al. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 98 (1996) 1150-1157
6. Ciubotariu R., Liu Z., Colovai A.I., Ho E., Itescu S., Ravalli S., et al. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 101 (1998) 398-405
7. Suciu-Foca N., Harris P.E., and Cortesini R. Intramolecular and intermolecular spreading during the course of organ allograft rejection. Immunol Rev 164 (1998) 241-246
8. Reed E.F., Hong B., Ho E., Harris P.E., Weinberger J., and Suciu-Foca N. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation 61 (1996) 566-572
9. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., et al. Tolerization of dendritic cells by T(S) cells: The crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3 (2002) 237-243
10. Liu J., Liu Z., Witkowski P., Vlad G., Manavalan J.S., Scotto L., et al. Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transpl Immunol 13 (2004) 239-247
11. Manavalan J.S., Kim-Schulze S., Scotto L., Naiyer A.J., Vlad G., Colombo P.C., et al. Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16 (2004) 1055-1068
12. Itescu S., Tung T.C., Burke E.M., Weinberg A., Moazami N., Artrip J.H., et al. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation 98 (1998) 786-793
13. Michaels P.J., Espejo M.L., Kobashigawa J., Alejos J.C., Burch C., Takemoto S., et al. Humoral rejection in cardiac transplantation: Risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 22 (2003) 58-69
14. Jacobs J.P., Quintessenza J.A., Boucek R.J., Morell V.O., Botero L.M., Badhwar V., et al. Pediatric cardiac transplantation in children with high panel reactive antibody. Ann Thorac Surg 78 (2004) 1703-1709
15. Lietz K., John R., Burke E., Schuster M., Rogers T.B., Suciu-Foca N., et al. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease. Circulation 112 (2005) 2468-2476
16. Zangwill S.D., Ellis T.M., Zlotocha J., Jaquiss R.D., Tweddell J.S., Mussatto K.A., and Berger S. The virtual crossmatch-a screening tool for sensitized pediatric heart transplant recipients. Pediatr Transplant 10 (2006) 38-41
17. Reed E.F., Demetris A.J., Hammond E., Itescu S., Kobashigawa J.A., Reinsmoen N.L., et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 25 (2006) 153-159
18. Kfoury A.G., Stehlik J., Renlund D.G., Snow G., Seaman J.T., Gilbert E.M., et al. Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: Defining rejection patterns. J Heart Lung Transplant 25 (2006) 1277-1282
19. Nwakanma L.U., Williams J.A., Weiss E.S., Russell S.D., Baumgartner W.A., and Conte J.V. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg 84 (2007) 1556-1562 discussion 1562-3
20. Holt D.B., Lublin D.M., Phelan D.L., Boslaugh S.E., Gandhi S.K., Huddleston C.B., et al. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. J Heart Lung Transplant 26 (2007) 876-882
21. Smith J.D., Hamour I.M., Banner N.R., and Rose M.L. C4d fixing, luminex binding antibodies-a new tool for prediction of graft failure after heart transplantation. Am J Transplant 7 (2007) 2809-2815
22. Kfoury A.G., Hammond M.E., Snow G.L., Stehlik J., Reid B.B., Long J.W., et al. Early screening for antibody-mediated rejection in heart transplant recipients. J Heart Lung Transplant 26 (2007) 1264-1269
23. Murata K., Fox-Talbot K., Qian Z., Takahashi K., Stahl G.L., Baldwin III W.M., and Wasowska B.A. Synergistic deposition of C4d by complement-activating and non-activating antibodies in cardiac transplants. Am J Transplant 7 (2007) 2605-2614
24. Holt D.B., Lublin D.M., Phelan D.L., Boslaugh S.E., Gandhi S.K., Huddleston C.B., et al. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. J Heart Lung Transplant 26 (2007) 876-882
25. Kobashigawa J., Mehra M., West L., Kerman R., George J., Rose M., et al. Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant 28 (2009) 213-225
26. Billingham M.E., Cary N.R., Hammond M.E., Kemnitz J., Marboe C., McCallister H.A., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 9 (1990) 587-593
27. Dixon W.J., Brown M.B., Engelman L., and Jennrich R.I. BMDP statistical software (1990), University of California Press
28. Cox D.R., and Oakes D. Analysis of survival data (1984), Chapman and Hall, London
29. Breslow N.E., and Day N.E. Statistical methods in cancer research. Volume I-The analysis of case-control studies. IARC Sci Publ (1980)
30. Baldwin W.M., Ota H., and Rodriguez E.R. Complement in transplant rejection: Diagnostic and mechanistic considerations. Springer Semin Immunopathol 25 (2003) 181-197
31. Wasowska B.A., Lee C.Y., Halushka M.K., and Baldwin III W.M. New concepts of complement in allorecognition and graft rejection. Cell Immunol 248 (2007) 18-30
32. Wehner J., Morrell C.N., Reynolds T., Rodriguez E.R., and Baldwin III W.M. Antibody and complement in transplant vasculopathy. Circ Res 100 (2007) 191-203
33. Ho E.K., Vasilescu E.R., Colovai A.I., Stokes M.B., Hallar M., Markowitz G.S., et al. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation. Transpl Immunol 20 (2008) 61-67
34. Vlad G., Ho E.K., Vasilescu E.R., Colovai A.I., Stokes M.B., Markowitz G.S., et al. Relevance of different antibody detection methods for prediction of antibody mediated rejection and deceased-donor kidney allograft survival. Hum Immunol (2009) doi:10.1016/j.humimm.2009.04.018
35. Chan G., Bivins-Smith E.R., Smith M.S., Smith P.M., and Yurochko A.D. Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J Immunol 181 (2008) 698-711
36. Benoit M., Desnues B., and Mege J.L. Macrophage polarization in bacterial infections. J Immunol 181 (2008) 3733-3739
37. Suciu-Foca N., Feirt N., Zhang Q.Y., Vlad G., Liu Z., Lin H., et al. Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients. J Immunol 178 (2007) 7432-7441
38. Vlad G., D'Agati V.D., Zhang Q.Y., Liu Z., Ho E.K., Mohanakumar T., et al. Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice. Diabetes 57 (2008) 1878-1886
39. Vlad G., Cortesini R., and Suciu-Foca N. CD8+ T suppressor cells and the ILT3 master switch. Hum Immunol 69 (2008) 681-686